Top Message

President & CEO

Japan Tissue Engineering Co., Ltd.
President & CEO

Kazuto Yamada

Since our establishment in 1999, we have been striving to realize our vision of "Creating a Future for Regenerative Medicine." By using products derived from patients' cells, we have continuously provided new treatments for diseases that were difficult to treat with conventional pharmaceuticals and medical devices.

The development of regenerative medicine has the potential to dramatically and sustainably improve patients' quality of life, and it is closely linked to sustainability. We deeply recognize our social responsibility to continuously provide high-quality and safe products and to ensure that treatment opportunities are equitably distributed to patients. This includes respecting patients' dignity to the fullest extent, fostering a healthy development of regenerative medicine through transparent information disclosure, and gaining understanding and trust from society as a whole.

The spread of regenerative medicine, which contributes to a sustainable healthcare system, requires the cultivation of talented individuals who will lead the future of regenerative medicine. By collaborating with industry, academia, and various government agencies, we aim to build a high-quality and practical education system to nurture the next generation of leaders. This will accelerate the advancement of regenerative medicine technology and maintain and enhance international competitiveness.

Together with all stakeholders, including patients, we believe that we can achieve improved health and welfare and a sustainable society through the power of regenerative medicine. We will continue to earnestly work towards contributing to people's health and the future of our planet.